Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
British Journal of Clinical Pharmacology|October 28, 2019
Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334sCharles S Venuto, Yoninah S Cramer, Susan L Rosenkranz, et al.Journal of Hepatology|February 27, 2013
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1Eric Lawitz, Fred Poordad, Kris V Kowdley, et al.Journal of Hepatology|June 25, 2017
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysisFred Poordad, David R Nelson, Jordan J Feld, et al.The Lancet. Gastroenterology & Hepatology|April 19, 2017
Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trialTania M Welzel, Tarik Asselah, Emily O Dumas, et al.The AAPS Journal|July 8, 2017
Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV InfectionAkshanth R Polepally, Haoyu Wang, Patrick J Marroum, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2003
Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individualsRajesh T Gandhi, Alysse Wurcel, Hang Lee, et al.Journal of Hepatology|April 4, 2015
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphineJacob Lalezari, J Greg Sullivan, Peter Varunok, et al.Journal of Medical Virology|December 13, 2019
Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disordersMichael Fuchs, Alexander Monto, Norbert Bräu, et al.The New England Journal of Medicine|January 4, 2013
Exploratory study of oral combination antiviral therapy for hepatitis CFred Poordad, Eric Lawitz, Kris V Kowdley, et al.Journal of Virological Methods|April 1, 2017
HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patientsJürgen Kurt Rockstroh, Jordan J Feld, Stéphane Chevaliez, et al.Pageof 5